Hofseth BioCare Strengthens Distribution in China
Company Announcements

Hofseth BioCare Strengthens Distribution in China

Hofseth Biocare ASA (HOFBF) has released an update.

Hofseth BioCare ASA expands its reach in China by appointing Lithy One-Health Group Technology Co. Ltd as a distributor for its marine nutrition ingredients, leveraging Lithy’s established presence and manufacturing capabilities in the nutraceutical and pharmaceutical markets. The partnership aims to enhance the distribution and development of HBC’s innovative health products, including ProGo, OmeGo, and CalGo, across the country.

For further insights into HOFBF stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskHofseth Biocare ASA Shows Strong Revenue Growth
TipRanks European Auto-Generated NewsdeskHofseth Biocare’s Breakthrough in Prostate Cancer
TipRanks European Auto-Generated NewsdeskHofseth BioCare Reports Strong Quarterly Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App